Lung cancer – Erlotinib
Reports looking at Erlotinib for the treatment of non-small cell lung cancer and the risk and costs of febrile neutropenia in patients with non-small cell lung cancer treated with docetaxel.
A Wailoo, A Sutton, A Morgan, The risk of febrile neutropenia in patients with non-small cell lung cancer treated with Docetaxel: a systematic review and meta-analysis 2009 British Journal of Cancer Vol 100: 436-441
A world top-100 university
We're a world top-100 university renowned for the excellence, impact and distinctiveness of our research-led learning and teaching.